TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Women With HER2-Positive Breast Cancer Brain Metastases

Conditions:   Breast Cancer;   Brain Metastases;   HER2-positive Breast Cancer;   CNS Disease Interventions:   Drug: Tucatinib;   Drug: Pembrolizumab;   Drug: Trastuzumab Sponsors:   Reva Basho;   Merck Sharp & Dohme Corp.;   Seattle Genetics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials